Abstract
Psychopharmacological interventions are incredibly successful in conjunction with rehabilitative treatment for opiate addiction. However, a comprehensive approach to addictions is necessary, and while pharmacotherapy plays an important role, it is insufficient on its own. A multidisciplinary team is an important part of treatment in order to address the behavioral and psychological elements we have described in this book. The team can implement treatment effectively and hold patients accountable in their recovery. Furthermore, our patients often have psychiatric and medical comorbidity that contributes to their addiction that must be addressed for success, including health concerns such as chronic diseases like hepatitis C, HIV, and chronic pain.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sontag D. The double-edged drug: addiction treatment with a dark side. November 16, 2013; The New York Times. Retrieved 1/31/2019 from https://www.nytimes.com/2013/11/17/health/in-demand-in-clinics-and-on-the-street-bupe-can-be-savior-or-menace.html.
Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction, DHHS publication no. SMS 07-3939. Rockville: Substance Abuse and Mental Health Services Administration; 2010.
Mendelson J, Flower K, Pletcher MJ, Galloway GP. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine. Exp Clin Psychopharmacol. 2008;16(5):435–41.
Substance Abuse and Mental Health Services Administration (SAMHSA). Medications for opioid use disorder, Treatment Improvement Protocol (TIP) Series 63, Full Document. HHS Publication No. (SMA) 18- 5063FULLDOC. Rockville: Substance Abuse and Mental Health Services Administration; 2018.
U.S. Food & Drug Administration. Approved Risk Evaluation and Mitigation Strategies (REMS): Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) REMS Programs. 2018. Accessed November 2018 from https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=9.
National Institute on Drug Abuse. Overdose death rates. 2018. Access November 2018 from https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates.
Substance Abuse and Mental Health Services Administration. SAMHSA opioid overdose prevention toolkit: safety advise for patients, HHS publication no. SMA 13-4742. Rockville: Substance Abuse and Mental Health Services Administration; 2013.
Quinn R. Heroin deaths in Delco at record high; fed study ranks county fourth in state for fatal overdoses. Delaware County Daily Times. 2015. Retrieved from http://www.delcotimes.com/article/DC/20151118/NEWS/151119573.
Whelan, J. Update on county response to opioid overdoses. 2015. Speech presented in PA, Sharon Hill.
White WL, Scott CK, Dennis ML, Boyle MG. It’s time to stop kicking people out of addiction treatment. Counselor. 2005;6(2):12–25. Retrieved from http://dbhids.org/wp-content/uploads/2015/07/2004-Possible-Resource-Papers-StopKickingPeopleOutofAddictionTreatment.pdf.
Morbidity and Mortality Weekly Report (MMWR). 2016, March 18. Accessed November 2018 from https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm?CDC_AA_refVal=https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1er.htm.
Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10. 2014;260:1–161. https://www.cdc.gov/nchs/data/series/sr_10/sr10_260.pdf.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hodgson, J., Moore, K., Acri, T., Treisman, G.J. (2020). Adjunctive Pharmacotherapy for Opioid Addictions. In: Integrative Medicine for Vulnerable Populations. Springer, Cham. https://doi.org/10.1007/978-3-030-21611-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-21611-5_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21610-8
Online ISBN: 978-3-030-21611-5
eBook Packages: MedicineMedicine (R0)